Treatment of metastatic colorectal carcinomas by systemic inhibition of vascular endothelial growth factor signaling in mice

查看全文 作　　者：Volker [1]Schmitz;Miroslaw [1]Kornek;Tobias [1]Hilbert;Christian [1]Dzienisowicz;Esbher [1]Raskopf;Christian [1]Rabe;Tilman [1]Sauerbruch;Cheng [2]Qian;Wolfgang H [3]Caselmann

机构地区：[1]Medizinische Klinik und Poliklinik I, Universitatsklinikum Bonn,Germany;[2]Universidad de Navarra, Clinica Universitaria, Pamplona, Spain;[3]Bavarian State Ministry of the Environment, Public Health and Consumer Protection, Munich 81901, Germany

出　　处：《World Journal of Gastroenterology》索引2005年第11卷第28期,共5页

基　　金：Supported by the Deutsche Krebshilfe, No. 70-3065-SchmI 摘　　要：AIM: Tumor angiogenesis has been shown to be promoted by vascular endothelial growth factor (VEGF) via stimulating endothelial cell proliferation, migration, and survival. Blockade of VEGF signaling by different means has been demonstrated to result in reduced tumor growth and suppression of tumor angiogenesis in distinct tumor entities. Here, we tested a recombinant adenovirus, AdsFIt1-3, that encodes an antagonistically acting fragment of the VEGF receptor 1 (Flt-1), for systemic antitumor effects in pre-established subcutaneous CRC tumors in mice. METHODS: Murine colorectal carcinoma cells (CT26) were inoculated subcutaneously into Balb/c mice for in vivo studies. Tumor size and survival were determined. 293 cell line was used for propagation of the adenoviral vectors. Human lung cancer line A549 and human umbilical vein endothelial cells were transfected for in vitro experiments. RESULTS: Infection of tumor cells with AdsFlt1-3 resulted in protein secretion into cell supernatant, demonstrating correct vector function. As expected, the secreted sFlt1-3 protein had no direct effect on CT26 tumor cell proliferation in vitro, but endothelial cell function was inhibited by about 46% as compared to the AdLacZ control in a tube formation assay. When AdsFlt1-3 (5×109 PFU/animal) was applied to tumor bearing mice, we found a tumor inhibition by 72% at d 12 after treatment initiation. In spite of these antitumoral effects, the survival time was not improved. According to reduced intratumoral microvessel density in AdsFIt1-3-treated mice, the antitumor mechanism can be attributed to angiostatic vector effects. We did not detect increased systemic VEGF levels after AdsFlt1-3 treatment and liver toxicity was low as judged by serum alanine aminotransferase determination. CONCLUSION: In this study we confirmed the value of a systemic administration of AdsFIt1-3 to block VEGF signaling as antitumor therapy in an experimental metastatic colorectal carcinoma model in mice. 关键词：结直肠癌血管生长因子小鼠动物实验

相关文献

参考文献（16）
引证文献（5）
耦合文献（0）

参考文献(16)

引证文献(5)

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

Treatment of metastatic colorectal carcinomas by systemic inhibition of vascular endothelial growth factor signaling in mice

参考文献(16)

引证文献(5)

用户提示